GM54724/GM/NIGMS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1999	3
2000	2
2001	2
2002	6
2003	7
2004	6
2005	6
2006	4
2007	5
2008	2
2010	1
2011	2
2021	0

1

Drugs as P-glycoprotein substrates, inhibitors, and inducers.

Kim RB. Kim RB. Drug Metab Rev. 2002 Feb-May;34(1-2):47-54. doi: 10.1081/dmr-120001389. Drug Metab Rev. 2002. PMID: 11996011 Review. No abstract available.

2

Transporters and xenobiotic disposition.

Kim RB. Kim RB. Toxicology. 2002 Dec 27;181-182:291-7. doi: 10.1016/s0300-483x(02)00296-2. Toxicology. 2002. PMID: 12505328 Review.

3

Transporters and renal drug elimination.

Lee W, Kim RB. Lee W, et al. Annu Rev Pharmacol Toxicol. 2004;44:137-66. doi: 10.1146/annurev.pharmtox.44.101802.121856. Annu Rev Pharmacol Toxicol. 2004. PMID: 14744242 Review.

4

Pharmacogenomics of organic anion-transporting polypeptides (OATP).

Tirona RG, Kim RB. Tirona RG, et al. Adv Drug Deliv Rev. 2002 Nov 18;54(10):1343-52. doi: 10.1016/s0169-409x(02)00077-7. Adv Drug Deliv Rev. 2002. PMID: 12406649 Review.

5

Transporters and drug discovery: why, when, and how.

Kim RB. Kim RB. Mol Pharm. 2006 Jan-Feb;3(1):26-32. doi: 10.1021/mp050084o. Mol Pharm. 2006. PMID: 16686366 Review.

6

Pharmacogenomics of the OATP and OAT families.

Marzolini C, Tirona RG, Kim RB. Marzolini C, et al. Pharmacogenomics. 2004 Apr;5(3):273-82. doi: 10.1517/phgs.5.3.273.29831. Pharmacogenomics. 2004. PMID: 15102542 Review.

7

Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.

Lockhart AC, Tirona RG, Kim RB. Lockhart AC, et al. Mol Cancer Ther. 2003 Jul;2(7):685-98. Mol Cancer Ther. 2003. PMID: 12883042 Free article. Review.

8

St John's wort-associated drug interactions: short-term inhibition and long-term induction?

Xie HG, Kim RB. Xie HG, et al. Clin Pharmacol Ther. 2005 Jul;78(1):19-24. doi: 10.1016/j.clpt.2005.04.002. Clin Pharmacol Ther. 2005. PMID: 16003288 Review. No abstract available.

9

Organic anion-transporting polypeptide (OATP) transporter family and drug disposition.

Kim RB. Kim RB. Eur J Clin Invest. 2003 Nov;33 Suppl 2:1-5. doi: 10.1046/j.1365-2362.33.s2.5.x. Eur J Clin Invest. 2003. PMID: 14641549 Review.

10

Transporters and drug therapy: implications for drug disposition and disease.

Ho RH, Kim RB. Ho RH, et al. Clin Pharmacol Ther. 2005 Sep;78(3):260-77. doi: 10.1016/j.clpt.2005.05.011. Clin Pharmacol Ther. 2005. PMID: 16153397 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results